Odoxil 125mg Suspension contains Cefadroxil, a first-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and some gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and pharyngitis caused by susceptible organisms. Cefadroxil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The oral suspension formulation of Odoxil 125mg provides an easily administrable option for pediatric and adult patients who have difficulty swallowing tablets. The dosage and duration of therapy should be determined based on the type and severity of infection as well as patient-specific factors such as age and renal function. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and hypersensitivity reactions including rash and pruritus. It is contraindicated in patients with a known hypersensitivity to cephalosporins or penicillins. Caution is advised in patients with renal impairment, and dose adjustment may be necessary. Odoxil 125mg Suspension should be used strictly under medical supervision to ensure appropriate use and to reduce the risk of antibiotic resistance.